Peter D. Friedmann, MD, MPH, DFASAM, FACP, is Chief Research Officer and Endowed Chair for Clinical Research, Baystate Health; Associate Dean for Research and Professor of Medicine and Healthcare Delivery & Population Sciences, University of Massachusetts Chan Medical School—Baystate. He was the founding director of the Center of Innovation in Long-Term Services and Supports at the Providence VA Medical Center and the Brown/Rhode Island Hospital Fellowship in Addiction Medicine. Dr. Friedmann has published over 210 peer-reviewed articles on the organization of treatment services, treatment process and outcomes, implementation of evidence-based practices for substance use disorders (SUDs) in medical, specialty addiction, and correctional settings, and the role of physicians in the care of patients with SUDs. He has had continuous funding from the National Institutes of Health since 1996 and was a Robert Wood Johnson Generalist Physician Faculty Scholar. He is a Distinguished Fellow of the American Society of Addiction Medicine and a Fellow of the American College of Physicians. He is a past president of the Association for Multidisciplinary Education and Research in Substance Use & Addiction (AMERSA) and former director on the American Board of Addiction Medicine. He serves as Editor-in-Chief for the Journal of Substance Use & Addiction Treatment.
Peter D. Friedmann, MD, MPH, DFASAM, FACP, is Chief Research Officer and Endowed Chair for Clinical Research, Baystate Health; Associate Dean for Research and Professor of Medicine and Healthcare Delivery & Population Sciences, University of Massachusetts Chan Medical School—Baystate. He was the founding director of the Center of Innovation in Long-Term Services and Supports at the Providence VA Medical Center and the Brown/Rhode Island Hospital Fellowship in Addiction Medicine. Dr. Friedmann has published over 210 peer-reviewed articles on the organization of treatment services, treatment process and outcomes, implementation of evidence-based practices for substance use disorders (SUDs) in medical, specialty addiction, and correctional settings, and the role of physicians in the care of patients with SUDs. He has had continuous funding from the National Institutes of Health since 1996 and was a Robert Wood Johnson Generalist Physician Faculty Scholar. He is a Distinguished Fellow of the American Society of Addiction Medicine and a Fellow of the American College of Physicians. He is a past president of the Association for Multidisciplinary Education and Research in Substance Use & Addiction (AMERSA) and former director on the American Board of Addiction Medicine. He serves as Editor-in-Chief for the Journal of Substance Use & Addiction Treatment.